Total Payments
$896.14
2024 Payments
$297.11
Companies
10
Transactions
45
Medicare Patients
1,673
Medicare Billing
$483,412
Payment Breakdown by Category
Food & Beverage$666.24 (74.3%)
Education$229.90 (25.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $666.24 | 39 | 74.3% |
| Education | $229.90 | 6 | 25.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Insmed, Inc. | $349.47 | 17 | $0 (2024) |
| ViiV Healthcare Company | $282.36 | 13 | $0 (2024) |
| Gilead Sciences, Inc. | $63.04 | 4 | $0 (2024) |
| Cumberland Pharmaceuticals, Inc. | $62.49 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $35.76 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $24.99 | 1 | $0 (2018) |
| Paratek Pharmaceuticals, Inc. | $24.00 | 2 | $0 (2019) |
| Shionogi Inc | $21.57 | 1 | $0 (2024) |
| Vyera Pharmaceuticals, LLC | $17.13 | 1 | $0 (2019) |
| PFIZER INC. | $15.33 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $297.11 | 14 | ViiV Healthcare Company ($140.19) |
| 2023 | $121.21 | 6 | ViiV Healthcare Company ($86.19) |
| 2022 | $68.44 | 4 | ViiV Healthcare Company ($55.98) |
| 2021 | $212.11 | 12 | Insmed, Inc. ($150.57) |
| 2020 | $12.37 | 1 | Insmed, Inc. ($12.37) |
| 2019 | $159.91 | 7 | Insmed, Inc. ($118.78) |
| 2018 | $24.99 | 1 | Astellas Pharma US Inc ($24.99) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: HIV | ||||||
| 11/07/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: HIV | ||||||
| 10/10/2024 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 09/05/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/22/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: HIV | ||||||
| 07/18/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Infections and Infectious Diseases | ||||||
| 07/11/2024 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 06/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: HIV | ||||||
| 05/30/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Respiratory | ||||||
| 05/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.67 | General |
| 04/11/2024 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 03/07/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: HIV | ||||||
| 01/11/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: HIV | ||||||
| 11/30/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/19/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: HIV | ||||||
| 08/03/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: HIV | ||||||
| 06/22/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: HIV | ||||||
| 05/11/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Respiratory | ||||||
| 03/30/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: HIV | ||||||
| 12/08/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: HIV | ||||||
| 09/01/2022 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: HIV | ||||||
| 08/04/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: HIV | ||||||
| 04/07/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Respiratory | ||||||
| 10/21/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 356 | 1,888 | $283,680 | $133,896 |
| 2022 | 6 | 412 | 1,669 | $247,780 | $113,560 |
| 2021 | 5 | 400 | 1,423 | $189,340 | $101,084 |
| 2020 | 5 | 505 | 1,986 | $255,090 | $134,872 |
Total Patients
1,673
Total Services
6,966
Medicare Billing
$483,412
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 152 | 1,614 | $209,820 | $97,931 | 46.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 154 | 190 | $57,000 | $25,114 | 44.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 69 | $13,110 | $8,842 | 67.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $3,750 | $2,008 | 53.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 166 | 1,374 | $178,620 | $76,142 | 42.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 85 | 91 | $27,300 | $13,828 | 50.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 96 | 116 | $24,940 | $12,224 | 49.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 54 | $10,320 | $7,584 | 73.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $3,750 | $2,262 | 60.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 19 | $2,850 | $1,520 | 53.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 171 | 1,129 | $126,410 | $66,481 | 52.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 175 | 202 | $42,510 | $22,311 | 52.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 29 | 66 | $14,520 | $8,991 | 61.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $3,660 | $2,089 | 57.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 14 | $2,240 | $1,212 | 54.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 222 | 1,634 | $179,740 | $95,832 | 53.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 223 | 278 | $58,380 | $31,109 | 53.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 31 | 43 | $9,460 | $4,682 | 49.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 16 | 16 | $4,960 | $2,181 | 44.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 15 | $2,550 | $1,068 | 41.9% |
About Dr. Jennifer Rudin, M.D
Dr. Jennifer Rudin, M.D is a Infectious Disease healthcare provider based in Monroeville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1821128109.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Rudin, M.D has received a total of $896.14 in payments from pharmaceutical and medical device companies, with $297.11 received in 2024. These payments were reported across 45 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($666.24).
As a Medicare-enrolled provider, Rudin has provided services to 1,673 Medicare beneficiaries, totaling 6,966 services with total Medicare billing of $483,412. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Monroeville, PA
- Active Since 03/06/2007
- Last Updated 09/20/2019
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1821128109
Products in Payments
- Arikayce (Drug) $349.47
- DOVATO (Drug) $258.15
- VIBATIV (Drug) $62.49
- APRETUDE (Biological) $24.21
- NUZYRA (Drug) $24.00
- Fetroja (Drug) $21.57
- ZERBAXA (Drug) $19.59
- Daraprim 30 Tablet in 1 Bottle (Drug) $17.13
- PIFELTRO (Drug) $16.17
- PAXLOVID (Drug) $15.33
- Veklury (Drug) $11.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.